Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference
Alpha Tau Medical (NASDAQ: DRTS, DRTSW), developer of the Alpha DaRT® alpha-radiation cancer therapy, has announced its participation in four upcoming investor conferences. CFO Raphi Levy will present at the following events:
1. H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, in New York, NY
2. Sidoti Small-Cap Virtual Investor Conference on September 19, 2024 (virtual)
3. Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference on September 26, 2024, in New York, NY
4. Lytham Partners Fall 2024 Investor Conference on October 1, 2024 (virtual)
Mr. Levy will be available for one-on-one investor meetings at all conferences. Interested parties should contact their respective conference representatives to schedule meetings.
Alpha Tau Medical (NASDAQ: DRTS, DRTSW), sviluppatore della terapia al cancerocare Alpha DaRT® a radiazione alfa, ha annunciato la sua partecipazione a quattro prossimi eventi di conferenza per investitori. Il CFO Raphi Levy presenterà ai seguenti eventi:
1. H.C. Wainwright 26ª Conferenza Globale Annuale sugli Investimenti il 10 settembre 2024, a New York, NY
2. Conferenza Virtuale per Investitori Sidoti Small-Cap il 19 settembre 2024 (virtuale)
3. Conferenza Radiopharma 2024 di Redburn Atlantic e Rothschild & Co il 26 settembre 2024, a New York, NY
4. Conferenza per Investitori Lytham Partners Autunno 2024 il 1 ottobre 2024 (virtuale)
Il Sig. Levy sarà disponibile per incontri individuali con gli investitori in tutte le conferenze. Le parti interessate dovrebbero contattare i relativi rappresentanti delle conferenze per programmare gli incontri.
Alpha Tau Medical (NASDAQ: DRTS, DRTSW), desarrollador de la terapia contra el cáncer Alpha DaRT® con radiación alfa, ha anunciado su participación en cuatro próximas conferencias para inversores. El CFO Raphi Levy presentará en los siguientes eventos:
1. 26ª Conferencia Global Anual de Inversiones H.C. Wainwright el 10 de septiembre de 2024 en Nueva York, NY
2. Conferencia Virtual de Inversores Small-Cap de Sidoti el 19 de septiembre de 2024 (virtual)
3. Conferencia de Radiopharma 2024 de Redburn Atlantic y Rothschild & Co el 26 de septiembre de 2024 en Nueva York, NY
4. Conferencia de Inversores Otoño 2024 de Lytham Partners el 1 de octubre de 2024 (virtual)
El Sr. Levy estará disponible para reuniones individuales con inversores en todas las conferencias. Las partes interesadas deberían contactar a sus respectivos representantes de la conferencia para programar reuniones.
알파 타우 메디컬 (NASDAQ: DRTS, DRTSW)는 알파 방사선 암 치료제인 Alpha DaRT®의 개발사로서 곧 열릴 네 개의 투자자 회의에 참석한다고 발표했습니다. CFO 라피 레비(Raphi Levy)가 다음 행사에서 발표할 예정입니다:
1. H.C. 웨인라이트 제26회 글로벌 투자 회의 2024년 9월 10일, 뉴욕, NY에서
2. 시도티 스몰캡 가상 투자자 회의 2024년 9월 19일(가상)
3. 레드번 애틀랜틱과 로스차일드 & Co 2024 방사선 제제 회의 2024년 9월 26일, 뉴욕, NY에서
4. 리탬 파트너스 2024 가을 투자자 회의 2024년 10월 1일(가상)
레비 씨는 모든 회의에서 투자자와의 일대일 미팅이 가능합니다. 관심 있는 분들은 회의의 각 대표자에게 연락하여 미팅 일정을 잡아야 합니다.
Alpha Tau Medical (NASDAQ: DRTS, DRTSW), développeur de la thérapie contre le cancer Alpha DaRT® à radiation alpha, a annoncé sa participation à quatre conférences pour investisseurs à venir. Le CFO Raphi Levy présentera lors des événements suivants :
1. 26e Conférence Globale Annuelle sur les Investissements de H.C. Wainwright le 10 septembre 2024 à New York, NY
2. Conférence Virtuelle pour Investisseurs Sidoti Small-Cap le 19 septembre 2024 (virtuelle)
3. Conférence Radiopharma 2024 de Redburn Atlantic et Rothschild & Co le 26 septembre 2024 à New York, NY
4. Conférence pour Investisseurs Automne 2024 de Lytham Partners le 1er octobre 2024 (virtuelle)
M. Levy sera disponible pour des réunions individuelles avec les investisseurs lors de toutes les conférences. Les parties intéressées doivent contacter les représentants respectifs des conférences pour planifier des réunions.
Alpha Tau Medical (NASDAQ: DRTS, DRTSW), Entwickler der Alpha DaRT® Alpha-Strahlen-Therapie für Krebs, hat seine Teilnahme an vier bevorstehenden Investorenkonferenzen angekündigt. CFO Raphi Levy wird auf den folgenden Veranstaltungen präsentieren:
1. 26. Jährliche Globale Investorenkonferenz von H.C. Wainwright am 10. September 2024 in New York, NY
2. Sidoti Small-Cap Virtuelle Investorenkonferenz am 19. September 2024 (virtuell)
3. Redburn Atlantic und Rothschild & Co 2024 Radiopharma-Konferenz am 26. September 2024 in New York, NY
4. Lytham Partners Herbst 2024 Investorenkonferenz am 1. Oktober 2024 (virtuell)
Herr Levy wird auf allen Konferenzen für Einzelgespräche mit Investoren zur Verfügung stehen. Interessierte Parteien sollten sich an die jeweiligen Konferenzvertreter wenden, um Meetings zu vereinbaren.
- None.
- None.
JERUSALEM, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present a corporate overview and update at the H.C. Wainwright 26th Annual Global Investment Conference on September 10th, 2024 and in the Sidoti Virtual Investor Conference on September 18-19th, 2024 and will participate in the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference on September 26th, 2024 and the Lytham Partners Fall 2024 Investor Conference on October 1st, 2024.
| Event: | H.C. Wainwright 26th Annual Global Investment Conference |
| Date: | September 10, 2024 |
| Time: | 12:00 – 12:30PM EST |
| Location: | New York, NY |
| Event: | Sidoti Small-Cap Virtual Investor Conference |
| Date: | September 19, 2024 |
| Time: | 11:30AM – 12:00PM EST |
| Location: | Virtual |
| Event: | Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference |
| Date: | September 26, 2024 |
| Time: | 8:30AM – 2:30PM EST |
| Location: | New York, NY |
| Event: | Lytham Partners Fall 2024 Investor Conference |
| Date: | October 1, 2024 |
| Time: | 8:00AM – 7:00PM EST |
| Location: | Virtual |
Mr. Levy will be available for 1x1 investor meetings at all conferences. Please reach out to your H.C. Wainwright, Sidoti, Rothschild & Co, or Lytham Partners representatives to schedule.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
About Alpha DaRT®
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.
Investor Relations Contact: IR@alphatau.com
FAQ
When is Alpha Tau Medical (DRTS) presenting at the H.C. Wainwright Global Investment Conference?
Which investor conferences will Alpha Tau Medical (DRTS) participate in during Fall 2024?
Who will represent Alpha Tau Medical (DRTS) at the upcoming investor conferences?
Are one-on-one meetings available with Alpha Tau Medical (DRTS) at these conferences?
What is the date and location of the Sidoti Small-Cap Virtual Investor Conference where Alpha Tau Medical (DRTS) is presenting?
